Roles of calcium and IP3 in impaired colon contractility of rats following multiple organ dysfunction syndrome

Abstract

The purpose of the present study was to explore changes in rat colon motility, and determine the roles of calcium and inositol (1,4,5)-triphosphate (IP3) in colon dysmotility induced by multiple organ dysfunction syndrome (MODS) caused by bacteria peritonitis. The number of stools, the contractility of the muscle strips and the length of smooth muscle cells (SMC) in the colon, the concentration of calcium and IP3 in SMC, and serum nitric oxide were measured. Number of stools, fecal weight, IP3 concentration in SMC and serum nitric oxide concentration were 0.77 ± 0.52 pellets, 2.51 ± 0.39 g, 4.14 ± 2.07 pmol/tube, and 113.95 ± 37.89 µmol/L, respectively, for the MODS group (N = 11) vs 1.54 ± 0.64 pellets, 4.32 ± 0.57 g, 8.19 ± 3.11 pmol/tube, and 37.42 ± 19.56 µmol/L for the control group (N = 20; P < 0.05). After treatment with 0.1 mM acetylcholine and 0.1 M potassium chloride, the maximum contraction stress of smooth muscle strips, the length of SMC and the changes of calcium concentration were 593 ± 81 and 458 ± 69 g/cm³, 48.1 ± 11.8 and 69.2 ± 15.7 µM, 250 ± 70 and 167 ± 48%, respectively, for the control group vs 321 ± 53 and 284 ± 56 g/cm³, 65.1 ± 18.5 and 87.2 ± 23.7 µM, 127 ± 35 and 112 ± 35% for the MODS group (P < 0.05). Thus, colon contractility was decreased in MODS, a result possibly related to reduced calcium concentration and IP3 in SMC.

Calcium; Smooth muscle; IP3; Nitric oxide

Braz J Med Biol Res, 2007; 40: 1389-1397.

Roles of calcium and IP₃ in impaired colon contractility of rats following multiple organ dysfunction syndrome

C. Zheyu¹ , Q. Qinghui ² and Y. Lunan¹

¹Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China

²The First Affiliated Hospital, Medical University of DaLian, China

References ^{Correspondence and Footnotes}

Abstract

The purpose of the present study was to explore changes in rat colon motility, and determine the roles of calcium and inositol (1,4,5)-triphosphate (IP₃) in colon dysmotility induced by multiple organ dysfunction syndrome (MODS) caused by bacteria peritonitis. The number of stools, the contractility of the muscle strips and the length of smooth muscle cells (SMC) in the colon, the concentration of calcium and IP₃ in SMC, and serum nitric oxide were measured. Number of stools, fecal weight, IP₃ concentration in SMC and serum nitric oxide concentration were 0.77 ± 0.52 pellets, 2.51 ± 0.39 g, 4.14 ± 2.07 pmol/tube, and 113.95 ± 37.89 µmol/L, respectively, for the MODS group (N = 11) vs 1.54 ± 0.64 pellets, 4.32 ± 0.57 g, 8.19 ± 3.11 pmol/tube, and 37.42 ± 19.56 µmol/L for the control group (N = 20; P < 0.05). After treatment with 0.1 mM acetylcholine and 0.1 M potassium chloride, the maximum contraction stress of smooth muscle strips, the length of SMC and the changes of calcium concentration were 593 ± 81 and 458 ± 69 g/cm³, 48.1 ± 11.8 and 69.2 ± 15.7 µM, 250 ± 70 and 167 ± 48%, respectively, for the control group vs 321 ± 53 and 284 ± 56 g/cm³, 65.1 ± 18.5 and 87.2 ± 23.7 µM, 127 ± 35 and 112 ± 35% for the MODS group (P < 0.05). Thus, colon contractility was decreased in MODS, a result possibly related to reduced calcium concentration and IP₃ in SMC.

Key words: Calcium, Smooth muscle, IP₃, Nitric oxide

Introduction

Although multiple organ dysfunction syndrome (MODS) is the most common cause of death in intensive care units, its pathophysiology is incompletely understood. MODS is frequently followed by gastrointestinal stasis, which can increase gut permeability and bacterial translocation. Bacteria and endotoxin from the gut lumen subsequently enter the portal or systemic circulation. In addition, the translocation of bacteria and endotoxin may lead to local inflammation with the production of cytokines and other inflammatory mediators. These intestinally derived mediators may exacerbate the systemic inflammatory response and MODS. A vicious cycle of increased intestinal permeability leading to toxic mediator release results in a further increase in gut permeability (1-3). Therefore, it is clear that increased gut permeability and bacterial translocation, which mainly result from gut stasis, play a role in MODS (4-7).

Calcium plays a key role in smooth muscle cell (SMC) contraction. The increase and fall of intracellular free Ca²⁺ initiates contraction and relaxation in smooth muscles (8). Lodato et al. (9) reported that gastrointestinal stasis during sepsis may be associated with gastrointestinal smooth muscle dysfunction. The septic syndrome is a systemic inflammatory response to invading microorganisms. This response is now believed to be the result of a cascade of mediators: microbial toxins, such as lipopolysaccharide endotoxin of Gram-negative bacteria, cause host release of potent proinflammatory mediators, which in turn are largely responsible for cardiovascular derangement, shock, and MODS. MODS is the result of sepsis in experimental animals. Endotoxin impairs smooth muscle contraction, in part by induction of nitric oxide (NO) synthase and enhanced NO production. Decreased ileal muscle contractility has been reported (9), but colon contractility in MODS animals has not been reported. Therefore, we postulated that colon contractility was weakened during MODS, possibly due to changes in calcium, inositol (1,4,5)-triphosphate (IP₃) and NO. The current study was designed to examine the changes in colon contraction and the role of calcium, IP₃ and NO in MODS.

Material and Methods

Material

Male Wistar rats weighing 200-250 g were supplied by the Center of Experimental Animals at Sichuan University. Animals were bred in a controlled environment with a 12-h light/dark cycle. A Biopac system MP150 Physiometer (Biopac, Goleta, CA, USA) was used to measure contractility of circular colon muscle strips. Laser-scanning confocal microscopy (Radiance 2000; Bio-Rad, Hertfordshire, UK) was used to determine the concentration of calcium in SMC. An image analysis system (Cimas 2000, Beijing, China) was used to observe the change in SMC length. Collagenase type II (Sigma, St. Louis, MO, USA), Fluo-3 AM, F-127 (Molecular Probes, Eugene, OR, USA), an IP₃ kit (Amersham Biosciences Inc., Pittsburgh, PA, USA), and an NO test kit were also used in this study.

Methods

Establishment of the MODS model. The study was approved for animal use by Sichuan University and conformed to the guidelines of the National Institutes of Health for the care and use of laboratory animals (10,11). Forty male Wistar rats were randomly divided into two groups of 20 animals each. The MODS model was established according to Zheyu (12). Briefly, a 1-mL suspension of 8 x 10⁸ CFU/mL O127H6 Escherichia coli (Sigma) containing 10% BaSO₄ was injected under sterile conditions into the abdominal cavity of the animals in the MODS group at 8:00 am. The control group was injected with 1 mL of normal saline.

Measurement of stool number. The rats in the two groups were housed separately during the 24-h observation period. The filter papers on the floor of the mouse cages were changed hourly and the number of stools was counted.

Immunohistochemistry

Inducible NO synthase (iNOS) immunostaining was performed on colon segments. Specimens were quenched in 3% H₂O₂-methanol for 20 min, washed with 50 mM phosphate-buffered saline (PBS) three times for 5 min each, incubated in 10% blocking serum for 30 min, and then incubated overnight at 4ºC with rabbit polyclonal antihuman iNOS antibody, which cross-reacts with rat iNOS (1:50 dilution, Endogen, Cambridge, MA, USA), followed by three 5-min washes in 50 mM PBS. The specimens were then incubated with biotinylated horse anti-rabbit antibody (1:250 dilution; Vector, Burlingame, CA, USA) at 4ºC for 4 h, washed three times in PBS for 5 min each, incubated with the streptavidin-peroxidase complex for 40 min (ABC Elite kit; Vector), washed three times for 5 min each in PBS, and developed with 0.05% diaminobenzidine tetrahydrochloride and 0.01% hydrogen peroxide in 0.5% Tris buffer for 5 min at room temperature. Specimens were rinsed and mounted in Gel-Mount (Biomeda Corp., Foster City, CA, USA), coverslipped and examined by light microscopy after staining (Nikon FXA, Fryer, Huntley, IL, USA). Antibodies were diluted in 50 mM PBS containing 0.2% bovine serum albumin (Sigma), 100 units/mL penicillin G, and 100 g/mL streptomycin (Boehringer Mannheim, Indianapolis, IN, USA).

Preparation and measurement of smooth muscle strips. Twenty-four hours after injection, the rats were killed, and the distal colon was rapidly removed and placed in cold pre-oxygenated Krebs-Ringer buffer (Sigma). Standard Krebs-Ringer buffer contained 137.4 mM Na⁺, 5.9 mM K⁺, 2.5 mM Ca²⁺, 1.2 mM Mg²⁺, 134 mM Cl^-, 15.5 mM HCO₃^-, 1.2 mM H₂PO₄^-, and 11.5 mM glucose. This physiological solution was gassed with 97% O₂-3% CO₂ to establish a pH of 7.4. The intestinal mucosa was curetted in order to obtain 15 five-mm circular muscle strips. One end of the strip was tied to a fixed post and the other attached to an isometric force transducer. In the organ chamber, each strip was allowed to equilibrate for at least 20 min, and stimulators were then added. The stimulators included 0.1 mM acetylcholine (Ach) and 0.1 M potassium chloride, whose concentrations were slightly modified according to the literature (13,14). The force of contraction produced by stimulators was recorded at increasing muscle lengths. After contractile activity was recorded, the length of each strip was measured, and each strip was removed, blotted lightly, and weighed. The cross-sectional area of each strip was calculated from length and weight data by assuming that the density of smooth muscle was 1.05 g/cm³. All force development was normalized for tissue cross-sectional area and is reported as stress (9).

Preparation of dispersed smooth muscle cells. SMC were isolated from the circular muscle layer of the rat colon as described previously, with slight modifications (15). Briefly, muscle strips were digested for 30 min at 31ºC in HEPES buffer, pH 7.4, of the following composition: 24.6 M HEPES, 115 M NaCl, 5.7 M KCl, 2.0 M KH₂PO₄, 1.9 M CaCl₂, 0.6 M MgCl₂, 5.6 M glucose, and 0.184% (w/v) DMEM and containing 0.1% type II collagenase and 0.01% trypsin inhibitor. The partly digested strips were washed with PBS and muscle cells were allowed to disperse spontaneously for 30 min. The cells were harvested by filtration through a 500-µm Nitex filter and centrifuged at 350 g for 10 min. The filtrate (cell suspension) was equilibrated for 20 min before the experiment. For some experiments, cells were permeabilized by a brief exposure to saponin (75 µg/mL for 4 min) and equilibrated in a cytosolic buffer.

Measurement of smooth muscle cell contraction

The contraction of SMC was measured using computerized image micrometry as described previously (16). Briefly, a 0.25-mL cell suspension consisting of 1 x 10⁴ cells was added to 0.1 mL of the solution containing the test agents. The reaction was interrupted after 1 min by adding 0.1 mL acrolein at a final concentration of 0.1%. Individual cell length was measured by computerized image micrometry and the average length of cells before and after adding the test agents was obtained for 50 randomly chosen cells. The contractile response after each agent was defined as the decrease in the average length of the 50 cells and expressed as a percentage of the length before agent administration (17,18).

Effect of L-N6-(1-iminoethyl)-lysine on smooth muscle strips and smooth muscle cells

The contractility of smooth muscle strips and SMC pretreated with 100 µM L-N6-(1-iminoethyl)-lysine (L-NIL) (19,20) was measured as described above.

Measurement of intracellular free Ca²⁺((Ca²⁺) i) in smooth muscle cells. Calcium concentration in the SMC was estimated using the Ca²⁺ indicator Fluo-3 AM and a laser-scanning confocal microscope as described by Jacques et al. (21). Briefly, freshly dissociated SMC were seeded onto glass coverslips and incubated with a Fluo-3 working solution (7.5 µmol Fluo-3 AM and 0.02% Pluronic F-127 dissolved in standard buffer) at 37ºC under an atmosphere of 5% CO₂. After a loading period of 30 min, the cells were washed with PBS to remove extracellular Fluo-3 AM followed by incubation for an additional 20 min. Coverslips mounted on the chamber slide (Molecular Probes) were placed on the plate of the confocal microscope. The fluorescence in the cell was excited at 488 nm by an argon-ion laser, and emission between 515-545 nm was detected with a photomultiplier. The amount of Fluo-3 fluorescence indicating the cytosolic Ca²⁺ concentration was recorded (22).

Determination of smooth muscle IP₃ and serum nitric oxide

One milliliter of a cell suspension containing 5 x 10⁹ SMC was place in an Eppendorf tube and the amount of IP₃ was measured by radioimmunoassay (23). Serum NO was estimated using a nitrate reductase method (11).

Statistical analysis

Unless otherwise indicated, data are reported as means ± SEM. Means were compared by ANOVA followed by comparisons of individual pairs of means using the Student t-test. The chi-square test was used to determine differences in mortality between groups and correlation analysis was also used in this study. The numbers of stools were compared by non-parametric statistical tests included in the SPSS, version 10.1, statistical analysis program (SPSS Inc., Chicago, IL, USA). The level of significance was set at P < 0.05 in all analyses.

Results

The pathobiology of multiple organ dysfunction syndrome in the rat model

Twenty-four hours after injection, 11 rats survived in the MODS group (45% mortality) compared to the control group in which all 20 rats survived (no mortality; P < 0.01 compared to the MODS group). Blood was sampled from the caudal vein and serum alanine aminotransferase (ALT) and blood urea nitrogen (BUN) were measured to determine liver and kidney function using an automatic biochemical analyzer (Hitachi-7110A, Tokyo, Japan). The levels of serum ALT and BUN in the control group (N = 20) were 49.51 ± 10.64 IU/L and 4.79 ± 1.14 M, respectively, whereas the serum ALT and BUN levels in the MODS group (N = 11) were three times higher than the upper limit observed in the control group (173.15 ± 30.97 IU/L and 16.79 ± 1.83 M, respectively). This difference was statistically significant and suggested that the liver and kidney function of the MODS group had been severely damaged. This model of MODS is based on the establishment of bacterial peritonitis, which results in a high-mortality rate. This characteristic makes the model well suited for observing pathological changes and the effects of treatment (24).

Determination of the effect of multiple organ dysfunction syndrome on stool number

The mean number of stools in the MODS group was 0.77 ± 0.52 per rat within 1 h and 17.48 ± 2.71 within 1 day (24 h) vs 1.54 ± 0.64 within 1 h and 36.96 ± 3.82 within 1 day (24 h) in the control group. The mean feces weight per rat for 1 day was 2.51 ± 0.39 in the MODS group vs 4.32 ± 0.57 g in the control group. These data showed obvious differences between the two groups.

Inducible nitric oxide synthase production in multiple organ dysfunction syndrome colon

Smooth muscle contractility of the intestine during sepsis or after surgical manipulation is regulated, in part, by iNOS activity (25,26). To test the hypothesis that induced NO contributes to the impairment of smooth muscle function of the colon following MODS we performed immunohistochemical techniques to confirm the finding of iNOS production in the colon in MODS at the protein level. iNOS protein was detected in the external muscularis of MODS colon, with the most prominent staining occurring in the longitudinal layer. Staining for iNOS protein was also observed in the submucosa of MODS colon but was patchier. Little iNOS protein was detected in the colon of the control group (Figure 1A,B).

Measurement of the contractile changes of muscle strips and smooth muscle cells and the effects of L-N6-(1-iminoethyl)-lysine on smooth muscle strips and smooth muscle cells

To determine if muscle dysfunction accompanied MODS, mechanical activity was assessed by measuring circular strip contractions. After treatment of the muscle strips with 0.1 mM Ach, the maximal contractile stress was 593 ± 81 in the control group and 321 ± 53 g/cm³ in the MODS group (P < 0.01). After the addition of 0.1 M potassium chloride, the maximal contractile stress was 458 ± 69 in the control group and 284 ± 56 g/cm³ in the MODS group (P < 0.01).

In the control group, the maximal contractile stress was 598 ± 74 g/cm³ for the strips pretreated with 100 µM L-NIL followed by treatment with 0.1 mM Ach and 461 ± 77 g/cm³ for the strips pretreated with 100 µM L-NIL followed by 0.1 M potassium chloride. There were no significant differences in the values obtained before and after using L-NIL (P > 0.05). In the MODS group, the maximal contractile stress of strips pretreated with 100 µM L-NIL followed by treatment with 0.1 mM Ach was 498 ± 72 g/cm³ and the maximal contractile stress of strips submitted to the same pretreatment followed by 0.1 M potassium chloride was 401 ± 57 g/cm³. There were significant differences in the values obtained before and after using L-NIL (P < 0.05; Figure 2).

Circular muscle strips from the colon of control rats generated low-amplitude spontaneous phasic contractions at a frequency of 18.1 ± 0.73 contractions/min. The frequency of spontaneous contractions of colon muscle strips in MODS animals decreased 40% (10.86 ± 0.39 contractions/min) compared to control rats (P < 0.05).

In the control group, the length of SMC in the resting state was 75.1 ± 19.8 µm. Following the addition of 0.1 mM Ach and 0.1 M potassium chloride, the length of SMC was 48.1 ± 8.8 and 69.2 ± 15.7 µm, respectively. For the MODS group, the length of SMC in the resting state was 113.2 ± 30.4 µm. Following the addition of 0.1 mM Ach and 0.1 M potassium chloride, the length of SMC was 65.12 ± 18.57 and 87.2 ± 23.7 µm, respectively. The differences in SMC length between groups was significant in both cases (P < 0.05).

When SMC were pretreated with 100 µM L-NIL their length in the resting state was 93.1 ± 26.3 µm in the MODS group. Following the addition of 0.1 mM Ach and 0.1 M potassium chloride, the length of SMC was 55.1 ± 9.7 and 71.24 ± 29.4 µm, respectively. The results obtained before and after using L-NIL were significant for the MODS group (P < 0.05; Figure 3) but not for the control group (P > 0.05).

Determination of the changes of calcium concentration in smooth muscle cells

Treatment with 0.1 mM Ach and 0.1 M potassium chloride led to an increase in the fluorescence intensity measured in the SMC. The average concentrations of calcium ions (fluorescence intensity ratio) in the resting state were 1 ± 0.7 in the SMC of the control group, and 0.7 ± 0.1 in the SMC of the MODS group (12). In the control group, the increase in fluorescence following the addition of 0.1 mM Ach and 0.1 M potassium chloride was 250 ± 70 and 167 ± 48%, respectively, as compared to 127 ± 35 and 112 ± 35% for the MODS group (P < 0.05; Figure 4).

Amount of IP₃ in smooth muscle cells and serum nitric oxide concentration

The amount of IP₃ in SMC was 4.14 ± 2.07 pmol/tube in the MODS group vs 8.19 ± 3.11 pmol/tube in the control group (t = 4.78, P < 0.05). The concentration of serum NO was 113.95 ± 37.89 µM in the MODS group vs 37.42 ± 19.56 µM in the control group (t = 7.21, P < 0.01; Tables 1 and 2).

Figure 1.
Immunohistochemical analysis of colon sections. Sections showing brown staining were defined as positive. A, Negative staining (arrow) for inducible nitric oxide synthase (iNOS) protein in a section from the control group. B, Positive staining (arrow) for iNOS protein in a section of the muscularis externa from the multiple organ dysfunction syndrome group (200X).

Figure 2.
Effect of L-N6-(1-iminoethyl)-lysine (L-NIL) on maximal contractile stress in multiple organ dysfunction syndrome (MODS). In the MODS group, the maximal contractile stress of muscle strips was 321 ± 53 g/cm³ after treatment with 0.1 mM acetylcholine (Ach), and 498 ± 72 g/cm³ after strips pretreated with 100 µM L-NIL were treated with 0.1 mM Ach. There were significant differences before and after the use of L-NIL (P < 0.05, Student t-test). The maximal contractile stress of the muscle strips was 284 ± 56 g/cm³ after treatment with 0.1 M potassium chloride (KCl) and 401 ± 57 g/cm³ after strips pretreated with 100 µM L-NIL were treated with 0.1 M KCl. There were significant differences before and after the use of L-NIL (P < 0.05, Student t-test).

Figure 3.
Effect of L-N6-(1-iminoethyl)-lysine (L-NIL) on cell length in multiple organ dysfunction syndrome (MODS). In the MODS group, cell length was 65.12 ± 18.57 and 87.2 ± 23.7 µm after the addition of 0.1 mM acetylcholine (Ach) and 0.1 M potassium chloride (KCl), respectively. When smooth muscle cells (SMC) were pretreated with 100 µM L-NIL, followed by the addition of 0.1 mM Ach and 0.1 M KCl, SMC length was 55.1 ± 9.7 and 71.24 ± 29.4 µm, respectively. There were significant differences in the data before and after the use of L-NIL in the MODS group (P < 0.05, Student t-test).

Figure 4.
The multiple organ dysfunction syndrome (MODS) group and the control group responded differently in terms of fluorescence intensity of calcium stimulated with 0.1 mM acetylcholine (Ach) and 0.1 M potassium chloride (KCl; P < 0.05, Student t-test).

Table 1.
Correlation between serum nitric oxide (NO) and colon contraction in the multiple organ disfunction syndrome group.

Table 2.
Correlation between smooth muscle cell inositol (1,4,5)-triphosphate (IP₃) and colon contraction in the multiple organ disfunction syndrome group.

Discussion

The first and optimal pathway for treating gastrointestinal function failure is to restore the motor function of the gut. (Ca²⁺)i plays an important role in regulating contraction and relaxation of smooth muscle. An increase in (Ca²⁺)i triggers contraction in smooth muscle while a fall in (Ca²⁺)i causes relaxation (27,28). In the cytoplasm of SMC, Ca²⁺ binds to calmodulin and the calcium-calmodulin complex combines with the catalytic subunit of myosin light chain (MLC) kinase to form a receptor leading to the phosphorylation of serine at position 19 in the MLC. Phosphorylation of Ser-19 of MLC then allows myosin ATPase to be activated by actin and muscle contraction takes place. When cytoplasmic (Ca²⁺)i is reduced, MLC phosphatase dephosphorylates MLC₂₀, thereby deactivating actomyosin ATPase and causing relaxation (29,30). Ca²⁺ is provided by both extracellular and intracellular sources (31-33).

In the present study, 20 rats in the control group and 11 rats in the MODS group were observed in each contractility study. It was found that the number and weight of feces were lower and the changes of contractile amplitude in the colon smooth muscle strips were less pronounced in the MODS group compared to control. Furthermore, the length of SMC, which represents the contractility of these cells, was greater in the MODS group than in the control group. These results suggest that, after MODS, the motor function of the colon was weakened. In order to study the mechanism of decreased gastrointestinal smooth muscle contraction in MODS, Ach and potassium chloride were used as activators to stimulate SMC contraction. Furthermore, we found that calcium concentration was lower in the MODS group than in the control group, suggesting that colon dysmotility in the MODS group could be related to a fall in calcium concentration. The cause of the decreased calcium concentration in colon SMC in the MODS group was not determined.

The amount of IP₃ in SMC measured by radioimmunoassay was lower in the MODS group than in the control group. A possible conclusion would be that the fall of calcium concentration correlated with the decreased IP₃ in colon SMC in the MODS group. IP₃ is a second messenger in the receptor-G protein-inositol lipid signal transduction pathway, which specifically binds to IP₃ receptors in the sarcoplasmic reticulum. The IP₃ receptors consists of four identical 260-kDa subunits joined by a non-covalent bond. When 3-4 sites are bound by IP₃, the conformation of the receptor complex is altered, the ionic channel is opened and Ca²⁺ is released from intracellular stores (34-36). Therefore, only when the amount of IP₃ in SMC is reduced below a certain threshold is the calcium concentration reduced. This is a potential mechanism of impaired colon contractility in MODS.

By immunohistochemical methods the expression of iNOS was observed in the colon of the MODS group but not in the colon of the control group. Furthermore, contractility was enhanced in the muscle strips and SMC treated with L-NIL, a selective iNOS antagonist. iNOS can produce excessive NO which is the important factor resulting in gastrointestinal stasis and in increased cGMP concentrations in the effector cells (37,38). cGMP can activate protein kinase G and protein kinase A in the cell plasma, causing SMC hyperpolarization, a reduction of Ca²⁺ influx, and an increase in Ca²⁺ uptake by the sarcoplasmic reticulum. Thus, smooth muscle is relaxed and gastrointestinal stasis suffers further deterioration (8,39,40). In the present experiment, the concentration of serum NO was higher in the MODS group than in the control group. Of course, increased serum NO was related to multiple organ dysfunction including circulatory, liver, renal, and respiratory dysfunction, as previously reported (41-43). However, the relation between serum NO and colon contraction in MODS was not mentioned in the cited studies. Therefore, our results only suggest that the reduction of colon contraction in the MODS group could be related to serum NO concentration.

MODS can cause a reduction of gastrointestinal contraction, which may be related to the fall of calcium concentration and IP₃ in SMC. Subsequently, the cGMP and inositol lipid signal transduction pathways are activated simultaneously, leading to the decrease of (Ca²⁺)i in SMC. Toxins and cytokines released during sepsis and MODS also unbalance hemodynamic parameters which, in turn, could induce gastrointestinal dysmotility. These factors should be considered when assessing colon motility, but they were not considered in the present study (6,9).

Address for correspondence: C. Zheyu, Department of General Surgery, West China Hospital, Sichuan University, Chengdu 610041, China. E-mail: [e-mail] or [e-mail]

Received July 29, 2005. Accepted April 3, 2007.

• 1. Overhaus M, Togel S, Pezzone MA, Bauer AJ. Mechanisms of polymicrobial sepsis-induced ileus. Am J Physiol Gastrointest Liver Physiol 2004; 287: G685-G694.
• 2. Swank GM, Deitch EA. Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J Surg 1996; 20: 411-417.
• 3. Chieveley-Williams S, Hamilton-Davies C. The role of the gut in major surgical postoperative morbidity. Int Anesthesiol Clin 1999; 37: 81-110.
• 4. Nathens AB, Marshall JC. Sepsis, SIRS, and MODS: what's in a name? World J Surg 1996; 20: 386-391.
• 5. Nieuwenhuijzen GA, Goris RJ. The gut: the `motor' of multiple organ dysfunction syndrome? Curr Opin Clin Nutr Metab Care 1999; 2: 399-404.
• 6. Hierholzer C, Kalff JC, Chakraborty A, Watkins SC, Billiar TR, Bauer AJ, et al. Impaired gut contractility following hemorrhagic shock is accompanied by IL-6 and G-CSF production and neutrophil infiltration. Dig Dis Sci 2001; 46: 230-241.
• 7. Eskandari MK, Kalff JC, Billiar TR, Lee KK, Bauer AJ. LPS-induced muscularis macrophage nitric oxide suppresses rat jejunal circular muscle activity. Am J Physiol 1999; 277: G478-G486.
• 8. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature 1994; 372: 231-236.
• 9. Lodato RF, Khan AR, Zembowicz MJ, Weisbrodt NW, Pressley TA, Li YF, et al. Roles of IL-1 and TNF in the decreased ileal muscle contractility induced by lipopolysaccharide. Am J Physiol 1999; 276: G1356-G1362.
• 10. Shock SA, Laeseke PF, Sampson LA, Lewis WD, Winter TC III, Fine JP, et al. Hepatic hemorrhage caused by percutaneous tumor ablation: radiofrequency ablation versus cryoablation in a porcine model. Radiology 2005; 236: 125-131.
• 11. Zheyu C, Lunan Y. Early changes of small intestine function in rats after liver transplantation. Transplant Proc 2006; 38: 1564-1568.
• 12. Zheyu C, Qinghui Q, Lixin L, Tao MA, Xu J, Zhang L, et al. Effects of emodin on Ca²⁺ signal transduction of smooth muscle cells in multiple organ dysfunction syndrome. J Surg Res 2006; 131: 80-85.
• 13. Pang JJ, Xu XB, Li HF, Zhang XY, Zheng TZ, Qu SY. Inhibition of beta-estradiol on trachea smooth muscle contraction in vitro and in vivo Acta Pharmacol Sin 2002; 23: 273-277.
• 14. Wu ZX, Yang QH, Ruan T, Lee LY. Influence of maturation on constrictive response to stimulation of C-fiber afferents in isolated guinea pig airways. Am J Physiol Lung Cell Mol Physiol 2004; 287: L168-L175.
• 15. Wang P, Bitar KN. Rho A regulates sustained smooth muscle contraction through cytoskeletal reorganization of HSP27. Am J Physiol 1998; 275: G1454-G1462.
• 16. Yamada H, Strahler J, Welsh MJ, Bitar KN. Activation of MAP kinase and translocation with HSP27 in bombesin-induced contraction of rectosigmoid smooth muscle. Am J Physiol 1995; 269: G683-G691.
• 17. Takeuchi M, Watanabe J, Horiguchi S, Karibe A, Katoh H, Baba S, et al. Interaction between L-type Ca²⁺ channels and sarcoplasmic reticulum in the regulation of vascular tone in isolated rat small arteries. J Cardiovasc Pharmacol 2000; 36: 548-554.
• 18. Ma T, Qi QH, Yang WX, Xu J, Dong ZL. Contractile effects and intracellular Ca²⁺ signalling induced by emodin in circular smooth muscle cells of rat colon. World J Gastroenterol 2003; 9: 1804-1807.
• 19. Lefebvre RA. Influence of endotoxin on contractility in the rat gastric fundus. Eur J Pharmacol 1997; 339: 201-209.
• 20. Dick JM, Lefebvre RA. Influence of different classes of NO synthase inhibitors in the pig gastric fundus. Naunyn Schmiedebergs Arch Pharmacol 1997; 356: 488-494.
• 21. Jacques D, Sader S, El-Bizri N, Chouffani S, Hassan G, Shbaklo H. Neuropeptide Y induced increase of cytosolic and nuclear Ca²⁺ in heart and vascular smooth muscle cells. Can J Physiol Pharmacol 2000; 78: 162-172.
• 22. Lin JL, Chen YW. A fixation method for non-cultured cells and the measurement of intracellular free calcium. Acta Laser Biology Sinica 1998; 7: 220-222.
• 23. Wappler F, Scholz J, Kochling A, Steinfath M, Krause T, Schulte am EJ. Inositol 1,4,5-trisphosphate in blood and skeletal muscle in human malignant hyperthermia. Br J Anaesth 1997; 78: 541-547.
• 24. Hu S, Sheng Z, Zhou B, Guo Z, Lu J, Xue L, et al. Study on delay two-phase multiple organ dysfunction syndrome. Chin Med J 1998; 111: 101-108.
• 25. Eskandari MK, Kalff JC, Billiar TR, Lee KK, Bauer AJ. Lipopolysaccharide activates the muscularis macrophage network and suppresses circular smooth muscle activity. Am J Physiol 1997; 273: G727-G734.
• 26. Kalff JC, Schraut WH, Billiar TR, Simmons RL, Bauer AJ. Role of inducible nitric oxide synthase in postoperative intestinal smooth muscle dysfunction in rodents. Gastroenterology 2000; 118: 316-327.
• 27. Ji G, Barsotti RJ, Feldman ME, Kotlikoff MI. Stretch-induced calcium release in smooth muscle. J Gen Physiol 2002; 119: 533-544.
• 28. Henkel CC, Asbun J, Ceballos G, del Carmen Castillo M, Castillo EF. Relationship between extra and intracellular sources of calcium and the contractile effect of thiopental in rat aorta. Can J Physiol Pharmacol 2001; 79: 407-414.
• 29. Makhlouf GM, Murthy KS. Signal transduction in gastrointestinal smooth muscle. Cell Signal 1997; 9: 269-276.
• 30. Flynn ER, Bradley KN, Muir TC, McCarron JG. Functionally separate intracellular Ca²⁺ stores in smooth muscle. J Biol Chem 2001; 276: 36411-36418.
• 31. White C, McGeown JG. Regulation of basal intracellular calcium concentration by the sarcoplasmic reticulum in myocytes from the rat gastric antrum. J Physiol 2000; 529 (Part 2): 395-404.
• 32. Somlyo AP, Somlyo AV. The sarcoplasmic reticulum: then and now. Novartis Found Symp 2002; 246: 258-268.
• 33. Lukyanenko V, Gyorke I, Gyorke S. Regulation of calcium release by calcium inside the sarcoplasmic reticulum in ventricular myocytes. Pflugers Arch 1996; 432: 1047-1054.
• 34. Nelson MT, Cheng H, Rubart M, Santana LF, Bonev AD, Knot HJ, et al. Relaxation of arterial smooth muscle by calcium sparks. Science 1995; 270: 633-637.
• 35. McCarron JG, Flynn ER, Bradley KN, Muir TC. Two Ca²⁺ entry pathways mediate InsP3-sensitive store refilling in guinea-pig colonic smooth muscle. J Physiol 2000; 525 (Pt 1): 113-124.
• 36. Karaki H, Ozaki H, Hori M, Mitsui-Saito M, Amano K, Harada K, et al. Calcium movements, distribution, and functions in smooth muscle. Pharmacol Rev 1997; 49: 157-230.
• 37. Moore FA. The role of the gastrointestinal tract in postinjury multiple organ failure. Am J Surg 1999; 178: 449-453.
• 38. Hierholzer C, Kalff JC, Billiar TR, Bauer AJ, Tweardy DJ, Harbrecht BG. Induced nitric oxide promotes intestinal inflammation following hemorrhagic shock. Am J Physiol Gastrointest Liver Physiol 2004; 286: G225-G233.
• 39. Weisbrodt NW, Pressley TA, Li YF, Zembowicz MJ, Higham SC, Zembowicz A, et al. Decreased ileal muscle contractility and increased NOS II expression induced by lipopolysaccharide. Am J Physiol 1996; 271: G454-G460.
• 40. Boyer JC, Magous R, Christen MO, Balmes JL, Bali JP. Contraction of human colonic circular smooth muscle cells is inhibited by the calcium channel blocker pinaverium bromide. Cell Calcium 2001; 29: 429-438.
• 41. Kengatharan KM, De Kimpe SJ, Thiemermann C. Role of nitric oxide in the circulatory failure and organ injury in a rodent model of gram-positive shock. Br J Pharmacol 1996; 119: 1411-1421.
• 42. Ruetten H, Southan GJ, Abate A, Thiemermann C. Attenuation of endotoxin-induced multiple organ dysfunction by 1-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase. Br J Pharmacol 1996; 118: 261-270.
• 43. Thiemermann C, Ruetten H, Wu CC, Vane JR. The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br J Pharmacol 1995; 116: 2845-2851.

Correspondence and Footnotes

Publication Dates

• Publication in this collection
  17 July 2007
• Date of issue
  Oct 2007

History

• Accepted
  03 Apr 2007
• Received
  29 July 2005